作者
- Antman, E.M. (21)
- Braunwald, E. (29)
- Califf, R.M. (12)
- Cannon, C.P. (12)
- Gibson, C.M. (14)
- Giugliano, R.P. (54)
- Harrington, R.A. (17)
- McCabe, C.H. (17)
- Morrow, D.A. (12)
- Newby, L.K. (11)
|
總筆數:54
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Methodologic drift in the assessment of TIMI grade 3 flow and itsimplications with respect to the reporting of angiographic trial results |
For the TIMI Study Group;Gibson, C.;Ryan, K.A.;Kelley, M.;Rizzo, M.J.;Mesley, R.;Murphy, S.;Swanson, J.;Marble, S.J.;Dodge, J.;Giugliano, R.P.;Cannon, C.P.;Antman, E.M.; |
American Heart Journal |
1999-06-01 |
查看 |
| Methodologic drift in the assessment of TIMI grade 3 flow and itsimplications with respect to the reporting of angiographic trial results |
For the TIMI Study Group;Gibson, C.;Ryan, K.A.;Kelley, M.;Rizzo, M.J.;Mesley, R.;Murphy, S.;Swanson, J.;Marble, S.J.;Dodge, J.;Giugliano, R.P.;Cannon, C.P.;Antman, E.M.; |
American Heart Journal |
1999-06-01 |
查看 |
| Effect of leukocytosis at initial examination on prognosis in patients withprimary unstable angina |
Lloyd-Jones, D.M.;Camargo, C.A.;Giugliano, R.P.;O'Donnell, C.J.; |
American Heart Journal |
2000-05-01 |
查看 |
| First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor(RPR 109891) in patients with recent acute coronary syndromes: Results ofthe TIMI 15A and 15B trials |
Giugliano, R.P.;McCabe, C.H.;Sequeira, R.F.;Frey, M.J.;Henry, T.D.;Piana, R.N.;Tamby, J.-F.;Jensen, B.K.;Nicolas, S.B.;Jennings, L.K.;Wise, R.J.;Braunwald, E.;for the TIMI 15A and 15B Investigators^*; |
American Heart Journal |
2000-07-01 |
查看 |
| First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor(RPR 109891) in patients with recent acute coronary syndromes: Results ofthe TIMI 15A and 15B trials |
Giugliano, R.P.;McCabe, C.H.;Sequeira, R.F.;Frey, M.J.;Henry, T.D.;Piana, R.N.;Tamby, J.-F.;Jensen, B.K.;Nicolas, S.B.;Jennings, L.K.;Wise, R.J.;Braunwald, E.;for the TIMI 15A and 15B Investigators^*; |
American Heart Journal |
2000-07-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with abedside myoglobin assay and the 12-lead electrocardiogram |
for the InTIME-II investigators;de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.; |
American Heart Journal |
2000-09-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
for the Thrombolysis in Myocardial Infarction (TIMI) Investigators;Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.; |
American Heart Journal |
2001-05-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Elevated serum creatinine is associated with 1-year mortality after acutemyocardial infarction |
Walsh, C.R.;O'Donnell, C.J.;Camargo, C.A.;Giugliano, R.P.;Lloyd-Jones, D.M.; |
American Heart Journal |
2002-12-01 |
查看 |
| Association of the timing of ST-segment resolution with TIMI myocardialperfusion grade in acute myocardial infarction |
Gibson, C.M.;Karha, J.;Giugliano, R.P.;Roe, M.T.;Murphy, S.A.;Harrington, R.A.;Green, C.L.;Schweiger, M.J.;Miklin, J.S.;Baran, K.W.;Palmeri, S.;Braunwald, E.;Krucoff, M.W.;INTEGRITI Study Group; |
American Heart Journal |
2004-05-01 |
查看 |
| Association of the timing of ST-segment resolution with TIMI myocardialperfusion grade in acute myocardial infarction |
Gibson, C.M.;Karha, J.;Giugliano, R.P.;Roe, M.T.;Murphy, S.A.;Harrington, R.A.;Green, C.L.;Schweiger, M.J.;Miklin, J.S.;Baran, K.W.;Palmeri, S.;Braunwald, E.;Krucoff, M.W.;INTEGRITI Study Group; |
American Heart Journal |
2004-05-01 |
查看 |
| Association of the timing of ST-segment resolution with TIMI myocardialperfusion grade in acute myocardial infarction |
Gibson, C.M.;Karha, J.;Giugliano, R.P.;Roe, M.T.;Murphy, S.A.;Harrington, R.A.;Green, C.L.;Schweiger, M.J.;Miklin, J.S.;Baran, K.W.;Palmeri, S.;Braunwald, E.;Krucoff, M.W.;INTEGRITI Study Group; |
American Heart Journal |
2004-05-01 |
查看 |
| Angiographic perfusion score: An angiographic variable that integrates bothepicardial and tissue level perfusion before and after facilitatedpercutaneous coronary intervention in acute myocardial infarction |
Gibson, C.M.;Murphy, S.A.;Morrow, D.A.;Aroesty, J.M.;Gibbons, R.J.;Gourlay, S.G.;Barron, H.V.;Giugliano, R.P.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2004-08-01 |
查看 |
| Angiographic perfusion score: An angiographic variable that integrates bothepicardial and tissue level perfusion before and after facilitatedpercutaneous coronary intervention in acute myocardial infarction |
Gibson, C.M.;Murphy, S.A.;Morrow, D.A.;Aroesty, J.M.;Gibbons, R.J.;Gourlay, S.G.;Barron, H.V.;Giugliano, R.P.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2004-08-01 |
查看 |
| The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment ElevationAcute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlledtrial evaluating the clinical benefits of early front-loaded eptifibatidein the treatment of patients with non-ST-segment elevation acute coronarysyndrome-Study design and rationale |
on behalf of the EARLY ACS Steering Committee;Giugliano, R.P.;Newby, L.K.;Harrington, R.A.;Gibson, C.M.;Van de Werf, F.;Armstrong, P.;Montalescot, G.;Gilbert, J.;Strony, J.T.;Califf, R.M.;Braunwald, E.; |
American Heart Journal |
2005-06-01 |
查看 |
| The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment ElevationAcute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlledtrial evaluating the clinical benefits of early front-loaded eptifibatidein the treatment of patients with non-ST-segment elevation acute coronarysyndrome-Study design and rationale |
on behalf of the EARLY ACS Steering Committee;Giugliano, R.P.;Newby, L.K.;Harrington, R.A.;Gibson, C.M.;Van de Werf, F.;Armstrong, P.;Montalescot, G.;Gilbert, J.;Strony, J.T.;Califf, R.M.;Braunwald, E.; |
American Heart Journal |
2005-06-01 |
查看 |
| Comparison of long-term mortality across the spectrum of acute coronarysyndromes |
Allen, L.A.;O'Donnell, C.J.;Camargo, C.A.;Giugliano, R.P.;Lloyd-Jones, D.M.; |
American Heart Journal |
2006-05-01 |
查看 |
| Comparison of long-term mortality across the spectrum of acute coronarysyndromes |
Allen, L.A.;O'Donnell, C.J.;Camargo, C.A.;Giugliano, R.P.;Lloyd-Jones, D.M.; |
American Heart Journal |
2006-05-01 |
查看 |
| Comparison of long-term mortality across the spectrum of acute coronarysyndromes |
Allen, L.A.;O'Donnell, C.J.;Camargo, C.A.;Giugliano, R.P.;Lloyd-Jones, D.M.; |
American Heart Journal |
2006-05-01 |
查看 |
| Comparison of long-term mortality across the spectrum of acute coronarysyndromes |
Allen, L.A.;O'Donnell, C.J.;Camargo, C.A.;Giugliano, R.P.;Lloyd-Jones, D.M.; |
American Heart Journal |
2006-05-01 |
查看 |
| Comparison of long-term mortality across the spectrum of acute coronarysyndromes |
Allen, L.A.;O'Donnell, C.J.;Camargo, C.A.;Giugliano, R.P.;Lloyd-Jones, D.M.; |
American Heart Journal |
2006-05-01 |
查看 |
| Management of ST-segment elevation myocardial infarction: Comparison ofthe updated guidelines from North America and Europe |
Thomas, D.;Giugliano, R.P.; |
American Heart Journal |
2009-11-01 |
查看 |
| Extent of ST-segment resolution after fibrinolysis adds improved riskstratification to clinical risk score for ST-segment elevation myocardialinfarction |
Harkness, J.R.;Sabatine, M.S.;Braunwald, E.;Morrow, D.A.;Sloan, S.;Wiviott, S.D.;Giugliano, R.P.;Antman, E.M.;Cannon, C.P.;Scirica, B.M.; |
American Heart Journal |
2010-01-01 |
查看 |
| An update on the IMProved Reduction of Outcomes: Vytorin EfficacyInternational Trial (IMPROVE-IT) design |
Califf, R.M.;Lokhnygina, Y.;Cannon, C.P.;Stepanavage, M.E.;McCabe, C.H.;Musliner, T.A.;Pasternak, R.C.;Blazing, M.A.;Giugliano, R.P.;Harrington, R.A.;Braunwald, E.; |
American Heart Journal |
2010-05-01 |
查看 |
| An update on the IMProved Reduction of Outcomes: Vytorin EfficacyInternational Trial (IMPROVE-IT) design |
Califf, R.M.;Lokhnygina, Y.;Cannon, C.P.;Stepanavage, M.E.;McCabe, C.H.;Musliner, T.A.;Pasternak, R.C.;Blazing, M.A.;Giugliano, R.P.;Harrington, R.A.;Braunwald, E.; |
American Heart Journal |
2010-05-01 |
查看 |
| Novel biomarkers in cardiovascular disease: Update 2010 |
Hochholzer, W.;Morrow, D.A.;Giugliano, R.P.; |
American Heart Journal |
2010-10-01 |
查看 |
| Evaluation of the novel factor Xa inhibitor edoxaban compared withwarfarin in patients with atrial fibrillation: Design and rationale for theEffective aNticoaGulation with factor xA next GEneration in AtrialFibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI48) |
Ruff, C.T.;Giugliano, R.P.;Antman, E.M.;Crugnale, S.E.;Bocanegra, T.;Mercuri, M.;Hanyok, J.;Patel, I.;Shi, M.;Salazar, D.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2010-10-01 |
查看 |
| Novel biomarkers in cardiovascular disease: Update 2010 |
Hochholzer, W.;Morrow, D.A.;Giugliano, R.P.; |
American Heart Journal |
2010-10-01 |
查看 |
| Evaluation of the novel factor Xa inhibitor edoxaban compared withwarfarin in patients with atrial fibrillation: Design and rationale for theEffective aNticoaGulation with factor xA next GEneration in AtrialFibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI48) |
Ruff, C.T.;Giugliano, R.P.;Antman, E.M.;Crugnale, S.E.;Bocanegra, T.;Mercuri, M.;Hanyok, J.;Patel, I.;Shi, M.;Salazar, D.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2010-10-01 |
查看 |
| Safety and efficacy of adjusted-dose eptifibatide in patients withacute coronary syndromes and reduced renal function |
Melloni, C.;James, S.K.;White, J.A.;Giugliano, R.P.;Harrington, R.A.;Huber, K.;Tricoci, P.;Armstrong, P.W.;Van de Werf, F.;Montalescot, G.;Califf, R.M.;Newby, L.K.; |
American Heart Journal |
2011-11-01 |
查看 |
| Safety and efficacy of adjusted-dose eptifibatide in patients withacute coronary syndromes and reduced renal function |
Melloni, C.;James, S.K.;White, J.A.;Giugliano, R.P.;Harrington, R.A.;Huber, K.;Tricoci, P.;Armstrong, P.W.;Van de Werf, F.;Montalescot, G.;Califf, R.M.;Newby, L.K.; |
American Heart Journal |
2011-11-01 |
查看 |
| Rationale and design of the EMBRACE STEMI Study: A phase 2a,randomized, double-blind, placebo-controlled trial to evaluate the safety,tolerability and efficacy of intravenous Bendavia on reperfusion injury inpatients treated with standard therapy including primary percutaneouscoronary intervention and stenting for ST-segment elevation myocardialinfarction |
Chakrabarti, A.K.;Feeney, K.;Abueg, C.;Brown, D.A.;Czyz, E.;Tendera, M.;Janosi, A.;Giugliano, R.P.;Kloner, R.A.;Weaver, W.D.;Bode, C.;Godlewski, J.;Merkely, B.;Gibson, C.M.; |
American Heart Journal |
2013-04-01 |
查看 |
| Radial versus femoral access, bleeding and ischemic events in patientswith non-ST-segment elevation acute coronary syndrome managed with aninvasive strategy |
Klutstein, M.W.;Westerhout, C.M.;Armstrong, P.W.;Giugliano, R.P.;Lewis, B.S.;Gibson, C.M.;Lutchmedial, S.;Widimsky, P.;Steg, P.G.;Dalby, A.;Zeymer, U.;Van de Werf, F.;Harrington, R.A.;Newby, L.K.;Rao, S.V.; |
American Heart Journal |
2013-04-01 |
查看 |
| Prevalence and clinical outcomes of undiagnosed diabetes mellitus andprediabetes among patients with high-risk non-ST-segment elevation acutecoronary syndrome |
Giraldez, R.R.;Clare, R.M.;Lopes, R.D.;Dalby, A.J.;Prabhakaran, D.;Brogan, G.X.;Giugliano, R.P.;James, S.K.;Tanguay, J.F.;Pollack, C.V.;Harrington, R.A.;Braunwald, E.;Newby, L.K.; |
American Heart Journal |
2013-06-01 |
查看 |
| Routine early eptifibatide versus delayed provisional use atpercutaneous coronary intervention in high-risk non-ST-segment elevationacute coronary syndromes patients: An analysis from the Early GlycoproteinIIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrometrial |
Bagai, A.;White, J.A.;Lokhnygina, Y.;Giugliano, R.P.;Van de Werf, F.;Montalescot, G.;Armstrong, P.W.;Tricoci, P.;Gibson, C.M.;Califf, R.M.;Harrington, R.A.;Newby, L.K.; |
American Heart Journal |
2013-09-01 |
查看 |
| Routine early eptifibatide versus delayed provisional use atpercutaneous coronary intervention in high-risk non-ST-segment elevationacute coronary syndromes patients: An analysis from the Early GlycoproteinIIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrometrial |
Bagai, A.;White, J.A.;Lokhnygina, Y.;Giugliano, R.P.;Van de Werf, F.;Montalescot, G.;Armstrong, P.W.;Tricoci, P.;Gibson, C.M.;Califf, R.M.;Harrington, R.A.;Newby, L.K.; |
American Heart Journal |
2013-09-01 |
查看 |
| Association between bleeding and mortality among women and men withhigh-risk acute coronary syndromes: Insights from the Early versus Delayed,Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial |
Kaul, P.;Tanguay, J.F.;Newby, L.K.;Hochman, J.S.;Westerhout, C.M.;Califf, R.M.;Tricoci, P.;Gibson, C.M.;Giugliano, R.P.;Harrington, R.A.;Van de Werf, F.;Armstrong, P.W.; |
American Heart Journal |
2013-10-01 |
查看 |
| Association of metabolic syndrome and its individual components withoutcomes among patients with high-risk non-ST-segment elevation acutecoronary syndromes |
EARLY ACS Investigators;Mehta, R.H.;Westerhout, C.M.;Zheng, Y.;Giugliano, R.P.;Huber, K.;Prabhakaran, D.;Harrington, R.A.;Newby, K.L.;Armstrong, P.W.; |
American Heart Journal |
2014-08-01 |
查看 |
| Evaluating cardiovascular event reduction with ezetimibe as an adjunctto simvastatin in 18,144 patients after acute coronary syndromes: Finalbaseline characteristics of the IMPROVE-IT study population |
Blazing, M.A.;Giugliano, R.P.;Cannon, C.P.;Musliner, T.A.;Tershakovec, A.M.;White, J.A.;Reist, C.;McCagg, A.;Braunwald, E.;Califf, R.M.; |
American Heart Journal |
2014-08-01 |
查看 |
| Systemic, noncerebral, arterial embolism in 21,105 patients with atrialfibrillation randomized to edoxaban or warfarin: Results from the EffectiveAnticoagulation With Factor Xa Next Generation in AtrialFibrillation-Thrombolysis in Myocardial Infarction Study 48 trial |
Geller, B.J.;Giugliano, R.P.;Braunwald, E.;Murphy, S.A.;Hanyok, J.J.;Jin, J.;Mercuri, M.;Antman, E.M.;Ruff, C.T.; |
American Heart Journal |
2015-10-01 |
查看 |
| Cost-effectiveness of edoxaban vs warfarin in patients with atrialfibrillation based on results of the ENGAGE AF-TIMI 48 trial |
ENGAGE AF-TIMI 48 Trial Investigators;Magnuson, E.A.;Vilain, K.;Wang, K.;Li, H.;Kwong, W.J.;Antman, E.M.;Ruff, C.T.;Giugliano, R.P.;Cohen, D.J.; |
American Heart Journal |
2015-12-01 |
查看 |
| High-degree atrioventricular block, asystole, and electro-mechanicaldissociation complicating non-ST-segment elevation myocardial infarction |
Pokorney, S.D.;Radder, C.;Schulte, P.J.;Al-Khatib, S.M.;Tricocci, P.;Van de Werf, F.;James, S.K.;Cannon, C.P.;Armstrong, P.W.;White, H.D.;Califf, R.M.;Gibson, C.M.;Giugliano, R.P.;Wallentin, L.;Mahaffey, K.W.;Harrington, R.A.;Newby, L.K.;Piccini, J.P.; |
American Heart Journal |
2016-01-01 |
查看 |
| High-degree atrioventricular block, asystole, and electro-mechanicaldissociation complicating non-ST-segment elevation myocardial infarction |
Pokorney, S.D.;Radder, C.;Schulte, P.J.;Al-Khatib, S.M.;Tricocci, P.;Van de Werf, F.;James, S.K.;Cannon, C.P.;Armstrong, P.W.;White, H.D.;Califf, R.M.;Gibson, C.M.;Giugliano, R.P.;Wallentin, L.;Mahaffey, K.W.;Harrington, R.A.;Newby, L.K.;Piccini, J.P.; |
American Heart Journal |
2016-01-01 |
查看 |
| Edoxaban vs warfarin in patients with nonvalvular atrial fibrillationin the US Food and Drug Administration approval population: An analysisfrom the Effective Anticoagulation with Factor Xa Next Generation in AtrialFibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48)trial |
Eisen, A.;Giugliano, R.P.;Ruff, C.T.;Nordio, F.;Gogia, H.S.;Awasty, V.R.;Henderson, D.A.;Mercuri, M.F.;Rutman, H.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2016-02-01 |
查看 |
|
|
|
